Animal Clinical Investigation (ACI) bridges the veterinary community with the pharmaceutical and biotechnology industries, working together to develop treatments for pets with cancer and other complex medical conditions. By working with pets with naturally occurring diseases, ACI also contributes to the growing body of research that informs human clinical development.
ACI’s success is based on collaboration with its network veterinarians that are cutting-edge ‘thought leaders’. Together ACI helps companies bring the safest and most effective therapies to market and help animal health companies develop new products for this market. To this end, ACI designs, conducts, and reports clinical field studies in compliance with FDA regulations and industry standards.